Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • National Labs Buying Next-Gen IBM Supercomputer

    Nov 14, 2014, 12:00 PM by Michael Croft
    Nature | Oak Ridge National Laboratory (ORNL) in Tennessee and the Lawrence Livermore National Laboratory in California announced today their plans to upgrade to a next-generation IBM supercomputer that will run at 150 petaflops.
    Full story
  • Google Increases Award in 'Nobel' Prize of Computing

    Nov 14, 2014, 08:00 AM by Michael Croft
    Mashable | Google has raised the stakes in the A.M. Turing Award, offering $1 million. The annual awards recognize "major contributions of lasting importance to computing," and until now have included a cash prize of $250,000.
    Full story
  • 11beta-HSD1 focused library from OTAVA

    Nov 14, 2014, 00:00 AM by Michael Croft
    VAUGHAN, ON - Nov 14, 2014 - 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1, 11beta-HSD1) is an NADPH-dependent enzyme, which catalyses conversion of inactive glucocorticoids 11-dehydrocorticosterone and cortisone to active corticosterone and cortisol and vice versa
    Full story
  • IBM Invests in Pathway Genomics' Watson-Powered Health App

    Nov 13, 2014, 08:00 AM by Michael Croft
    Bio-IT World | Pathway Genomics yesterday announced an investment from IBM to launch Pathway Panorama, a health-focused mobile app powered by IBM’s Watson’s natural language processing technology and fed by data from Pathway Genomics’ genetic tests.
    Full story
  • Inactivated Protein Lowers Risk of Coronary Heart Disease by 53%

    Nov 12, 2014, 15:00 PM by Michael Croft
    Bio-IT World | A sequencing study published tomorrow in the New England Journal of Medicine has further characterized the activity of the Niemann-Pick C1-like 1 protein (NPC1L1). Carriers of inactivating mutations of NPC1L1 were found to have a 53% lower risk of coronary heart disease and an average LDL cholesterol level 12 mg per deciliter lower than that of noncarriers.
    Full story
  • ARUP Laboratories and PierianDx Create Partnership to Produce More Efficient and Effective Diagnostic Genetic Tests

    Nov 12, 2014, 00:00 AM by Michael Croft
    SALT LAKE CITY AND ST LOUIS, MO, US - Nov 12, 2014 - ST LOUIS and SALT LAKE CITY (Nov. 12, 2014) – ARUP Laboratories and PierianDx announced today a partnership that will result in faster and more efficient diagnostic genetic testing for thousands of patients across the U
    Full story
  • De Novo Human Genome Assembly Using Long Reads

    Nov 10, 2014, 13:40 PM by Michael Croft
    Bio-IT World News Brief | Evan Eichler of the University of Washington and colleagues have published a paper in Nature detailing a new whole human genome assembly, using the long-reading SMRT sequencing technology of Pacific Biosciences.
    Full story
  • Breakthrough Prizes Highlight CRISPR Gene Editing, Gene Regulation

    Nov 10, 2014, 11:10 AM by Michael Croft
    Bio-IT World | Emmanuelle Charpentier and Jennifer Doudna, co-discoverers of the CRISPR-Cas9 mechanism that has swiftly become a groundbreaking tool in genetic engineering, are among this year's winners of the $3 million Breakthrough Prizes in the Life Sciences awarded by a coalition of tech billionaires.
    Full story
  • BaseHealth CEO Jorge Velarde Speaks About the New Market for Genomic Health

    Nov 7, 2014, 10:05 AM by Michael Croft
    Bio-IT World | As a new crop of patient-facing genomic health companies adjusts to cheaper DNA data and more intense FDA oversight, Jorge Velarde, a former Illumina executive and the new CEO of BaseHealth, tells Bio-IT World what we can expect from this second wave of interest in our genomes' influence on health.
    Full story
  • CREBBP focused library from OTAVA

    Nov 7, 2014, 00:00 AM by Michael Croft
    - Nov 7, 2014 - CREB-binding protein (CREBBP, CBP) is a transcriptional coactivator of a broad range of transcription factors
    Full story
  • What a Big Data Buy Could Mean

    Nov 6, 2014, 15:00 PM by Michael Croft
    ReadWrite | One acquisition in the Big Data space could change everything, one analyst predicts, pointing out that if Oracle or Cisco were to snap up one of the Big Data start-ups the collateral damage would be severe.
    Full story
  • Genome Storage for $25

    Nov 6, 2014, 15:00 PM by Michael Croft
    Technology Review | Google Genomics says it is storing at least 3,500 genomes at the rate of $25 per genome per year. The analytics cost extra.
    Full story
  • Google to Cover Foundation Medicine Tests for All Employees

    Nov 6, 2014, 10:05 AM by Michael Croft
    BetaBoston | Foundation Medicine, the largest and most visible provider of broad genetic tests for personalized cancer therapy, announced this week that Google will pay for its tests for anyone covered under Google health plans.
    Full story
  • MolecularHealth to Speak at the 10th Annual Personalized Medicine Conference

    Nov 6, 2014, 00:00 AM by Michael Croft
    THE WOODLANDS, TX, UNITED STATES - Nov 6, 2014 - MolecularHealth announced today that Medical Director Gabriel Bien-Willner, M.D., Ph.D., will speak at this year’s Personalized Medicine Conference
    Full story
  • AstraZeneca Buys Definiens in Bid for Ground-Up Co-Diagnostics Pipeline

    Nov 5, 2014, 09:05 AM by Michael Croft
    Bio-IT World News Brief | AstraZeneca announced that it has acquired Definiens, a diagnostics company specializing in image analysis software, as part of a strategy to refine its immuno-oncology programs.
    Full story
  • Cloud Pharmaceuticals Announces World-Class Board of Directors

    Nov 5, 2014, 00:00 AM by Michael Croft
    RESEARCH TRIANGLE PARK, UNITED STATES - Nov 5, 2014 - Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, announced today that it ratified its board of directors at its annual meeting on September 16, 2014
    Full story
  • Takara Bio Selects Genedata Software to Automate and Standardize NGS Data Analysis

    Nov 5, 2014, 00:00 AM by Michael Croft
    TOKYO, JAPAN - Nov 5, 2014 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that Takara Bio Inc
    Full story
  • Know More about Single-Cell Sequencing to Achieve More Biology Findings

    Nov 5, 2014, 00:00 AM by Michael Croft
    SHIRLEY, NY - Nov 5, 2014 - As cell is the basic unit of biology, more and more scientists are trying to separate, study and compare cells
    Full story
  • October News and Product Briefs

    Nov 4, 2014, 10:30 AM by Michael Croft
    Bio-IT World | News and product releases from around the industry, including the GIANT Consortium's record-breaking GWAS, a new organ-on-a-chip company, and plenty of announcements from the annual meeting of the American Society for Human Genetics.
    Full story
  • PRESS RELEASE: NEW STARTUP ‘BIO DATA BRIDGES’ OFFERS LAB DATA MANAGEMENT HEALTH CHECK™

    Nov 4, 2014, 00:00 AM by Michael Croft
    SEATTLE, WA - Nov 4, 2014 - The challenge of future-proofing scientific data systems just got a lot easier for life science companies
    Full story
  • «
  • 381
  • 382
  • 383
  • 384
  • 385
  • 386
  • 387
  • 388
  • 389 (current)
  • 390
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy